MedTrace Logo

The Tomosynthesis Trial in Bergen - Part 2

NCT03669926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31082

Last updated 2024-08-28

No results posted yet for this study

Summary

The aim of the study is to compare early performance measures and economic aspects of organized breast cancer screening for women screened using digital breast tomosynthesis+synthetic mammography (DBT+SM) to women with a prior DBT+SM or digital mammography (DM) from To-Be 1 (NCT02835625).

Conditions

  • Breast Neoplasms

Interventions

RADIATION

Digital Breast Tomosynthesis+synthetic mammography

Two-view tomosynthesis performed with GE Senographe Pristina.

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • Norwegian Cancer Society

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Solveig Hofvind, Professor · Norwegian Institute of Public Health

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
48 Years
Max Age
71 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-06-30
Completion
2023-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03669926 on ClinicalTrials.gov